Research

In the Peters lab, we are using the power of bacterial genetics to address critical issues in the bioeconomy and antimicrobial resistance. Our CRISPR-based functional genomics approaches will allow us to define the roles of gene networks in the process of using microbes to convert plant material into valuable biofuels and bioproducts as well as in antibiotic targeting and resistance. We are currently developing innovative CRISPR tools for exploration of gene function in bioenergy-relevant alpha-Proteobacteria (Zymomonas mobilis, Rhodobacter sphaeroides, and Novosphingobium aromaticivorans) and antibiotic resistant, Gram-negative ESKAPE pathogens (Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae).